Heng Chi (H Chi)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Mesenchymal Stem Cells

African American

Top Venues

Journal of viral hepatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Kin Seng Liem, Heng Chi, Scott Fung, David K Wong, Colina Yim, Seham Noureldin, Jiayun Chen, Robert A de Man, Arif Sarowar, Jordan J Feld, Bettina E Hansen, Jin-Lin Hou, Jie Peng, Harry L A Janssen
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B. Journal of viral hepatitis 29 (11) (2022)
Stijn Van Hees, Heng Chi, Bettina Hansen, Stefan Bourgeois, Hans Van Vlierberghe, Thomas Sersté, Sven Francque, David Wong, Dirk Sprengers, Christophe Moreno, Frederik Nevens, Harry L A Janssen, Thomas Vanwolleghem
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion. Journal of viral hepatitis 26 (6) (2019)
Heng Chi, A Japhary, R A de Man, R J de Knegt, H L A Janssen, B E Hansen
Younger age and language barriers are associated with nonadherence to clinical follow-up in hepatitis B treatment. Journal of viral hepatitis 25 (10) (2018)
Margo J H van Campenhout, Willem Pieter Brouwer, Qing Xie, S Guo, Heng Chi, Xun Qi, Fehmi Tabak, Adrian Streinu-Cercel, Ji-Yao Wang, Ning-Ping Zhang, Ramazan Idilman, Hendrik W Reesink, Mircea Diculescu, Krzysztof Simon, Meral Akdogan, Włodzimierz Mazur, Rob J de Knegt, Elke Verhey, Bettina E Hansen, Harry L A Janssen, null null
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up. Journal of viral hepatitis 26 (1) (2018)